Loading…
Harbin-based household/personal-care products company; specific product lines not independently confirmed.
Harbin-based household/personal-care products company; specific product lines not independently confirmed.
Moat: none
Headquarters: Harbin, China · Employees: 869
Size Harbin Fuerjia Technology (301371.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $1.58B, the 1554th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥20.36 on 6 Nov 2026.
Performance Over six months the shares fell 29.9%, against -1.5% for the median peer and -16.4% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 28.0% over the last twelve months (peer median +5.0%); the operating margin is 19.9% (peer median 9.2%).
Valuation It trades at 22.5× forward earnings against a peer median of 18.8× (8th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 8.8 points above its cost of capital (9.8% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥2.37B | CN¥1.88B | CN¥1.99B | CN¥1.90B | CN¥1.75B |
| Revenue growth | — | -6% | +5% | +9% | — |
| Gross profit | CN¥1.85B | CN¥1.48B | CN¥1.60B | CN¥1.54B | CN¥1.45B |
| EBITDA | n/a | CN¥488M | CN¥803M | CN¥942M | CN¥1.01B |
| Net income | CN¥470M | CN¥433M | CN¥661M | CN¥749M | CN¥847M |
| Free cash flow | CN¥376M | CN¥342M | CN¥489M | CN¥756M | CN¥507M |
| Capital expenditure | CN¥21.8M | CN¥40.1M | CN¥121M | CN¥120M | CN¥398M |
| Total debt | CN¥14.2M | CN¥6.95M | CN¥11.1M | CN¥8.15M | CN¥912,785 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301371.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.1% | +2.7% | 7th lowest of 21 |
| 6-month return | -29.9% | -1.5% | 3rd lowest of 21 |
| Distance from 52-week high | -39.0% | -27.1% | 5th lowest of 21 |
| Revenue growth (TTM) | +28.0% | +5.0% | 3rd highest of 21 |
| Operating margin | 19.9% | 9.2% | 5th highest of 21 |
| Forward P/E | 22.5× | 18.8× | 8th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 8.7% | 4.3% | 7th most demanding of 17 |
| Growth delivered (Del g) | +3.6% | +9.5% | 7th lowest of 17 |
| Hurdle (Req g minus delivered) | +5.0 pp | -6.9 pp | 5th most demanding of 17 |
| ROIC minus cost of capital | +8.8 pp | +5.7 pp | 7th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |